Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,002 | 61,595 | 76,707 | 104,641 | 128,182 |
| Receivables | 8,156 | 1,949 | 7,127 | 666 | 282 |
| Inventories | 1,525 | 2,600 | 2,632 | 2,911 | 2,845 |
| TOTAL | $55,824 | $67,915 | $88,904 | $113,942 | $134,975 |
| Non-Current Assets | |||||
| PPE Net | 3,023 | 3,220 | 3,412 | 3,617 | 3,718 |
| Other Non-Current Assets | 4,996 | 5,351 | 5,315 | 5,882 | 5,504 |
| TOTAL | $8,019 | $8,571 | $8,727 | $9,499 | $9,222 |
| Total Assets | $63,843 | $76,486 | $97,631 | $123,441 | $144,197 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,949 | 7,717 | 7,498 | 7,285 | 37,371 |
| Accounts payable and accrued liabilities | 7,227 | 13,662 | 14,031 | 17,712 | 10,584 |
| Accrued Expenses | 24,765 | 22,832 | 16,984 | 18,954 | 22,133 |
| Other current liabilities | 602 | 1,864 | 1,772 | 1,757 | 1,743 |
| TOTAL | $40,646 | $46,299 | $40,752 | $46,354 | $72,409 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,311 | 13,378 | 15,375 | 17,314 | 19,124 |
| Deferred Revenues | 103 | 224 | 467 | 646 | 578 |
| Other Non-Current Liabilities | 3,804 | 3,930 | 4,222 | 4,418 | 4,520 |
| TOTAL | $15,440 | $17,670 | $20,124 | $22,344 | $24,375 |
| Total Liabilities | $56,086 | $63,969 | $60,876 | $68,698 | $96,784 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,226 | 28,238 | 28,282 | 28,293 | 28,056 |
| Common Shares | 2,170,300 | 2,168,237 | 2,163,174 | 2,161,013 | 2,157,300 |
| Retained earnings | -2,150,326 | -2,143,954 | -2,114,771 | -2,095,005 | -2,098,317 |
| Other shareholders' equity | -12,217 | -11,766 | -11,648 | -11,265 | -11,570 |
| TOTAL | $7,757 | $12,517 | $36,755 | $54,743 | $47,413 |
| Total Liabilities And Equity | $63,843 | $76,486 | $97,631 | $123,441 | $144,197 |